Direct answer: will bariatric surgery cure my sleep apnea?
It will dramatically improve OSA in most patients but not always eliminate it. The published evidence shows AHI drops by 19 to 23 events per hour on average, and about 65% of patients reach clinical remission at 12 months. The 2024 MOSAIC study in JACC (13,657 patients) found bariatric surgery was associated with a 42% reduction in major cardiac events and 37% reduction in mortality at 10 years.
Critical: do not stop your CPAP based on how you feel. Re-evaluate with a polysomnography at 12 months. Patients who self-discontinue CPAP without confirmation have higher rates of weight regain and persistent untreated OSA.
My short rule is this:
- Moderate-to-severe OSA with BMI above 35: strong indication for surgery.
- CPAP intolerance plus obesity: surgery is often the better long-term answer.
- Severe pre-op AHI above 60, age above 60, or significant anatomical contributors: expect improvement but plan for some continued treatment.
The 30-second summary
Bariatric surgery is the most effective long-term treatment for severe obstructive sleep apnea in people who carry significant obesity. Meta-analyses across 2,300+ patients show AHI drops by an average of 19 to 23 events per hour, and roughly 65% of patients reach clinical remission within 12 months. A 2024 study in the Journal of the American College of Cardiology following 13,657 patients with OSA and obesity found that those who had bariatric surgery had a 42% lower risk of major cardiac events and 37% lower risk of death over 10 years compared to those who did not. That said, I have to be honest with you. Surgery often improves OSA dramatically but does not always eliminate it. The decision to stop CPAP should be made with a post-op sleep study, not with the feeling that you no longer snore. Here is the real picture.
Why I treat sleep apnea seriously, even in patients who feel fine
Most patients who walk into my consultation with severe obesity have sleep apnea. They do not always know it. The published prevalence of OSA in bariatric surgery candidates is around 70%, and roughly 60% of those cases are undiagnosed at the time of surgical evaluation. If you have a BMI above 35 and you are not screened for OSA before surgery, you and your surgeon are flying blind on a real anesthetic risk.
Here is what is happening in your airway at night.
When you sleep, the muscles holding your upper airway open relax. If you have excess fat in the neck, in the tongue base, and around the pharyngeal walls, your airway collapses on itself with each breath. Your oxygen saturation drops. Your brain wakes you up briefly to restart breathing. You do not remember those awakenings, but they happen 15, 30, sometimes 60 times an hour. That is what the AHI (apnea-hypopnea index) measures.
The consequences are not just being tired. Untreated OSA accelerates hypertension, atrial fibrillation, stroke, heart failure, and metabolic disease. It also makes weight loss harder, because the chronic sleep fragmentation pushes ghrelin up and leptin down, and you wake up hungry no matter what you ate the day before.
This is why every patient in my practice who is a bariatric candidate gets screened with the STOP-Bang questionnaire before surgery. Score of 3 or higher is the standard cutoff that triggers a referral for polysomnography (4 or higher in some bariatric populations because the prevalence is so high). The STOP-Bang has a sensitivity of 93% for detecting moderate-to-severe OSA. We do not skip this step.
What actually happens to your sleep apnea after a gastric sleeve
Let me give you the timeline I see in my own patients.
First 3 months. As visceral and cervical fat melt off, the airway gains room. Snoring softens. Daytime sleepiness eases noticeably. The Epworth Sleepiness Scale usually drops. Patients tell me, around month 2 or 3, that their partners are sleeping better. This is real. But it is not the same as the AHI being normalized. Your sleep study would still show events.
Months 4 through 12. Weight loss peaks around month 12 with the Enhanced Gastric Sleeve. This is where you see the biggest improvements on polysomnography. A 2023 meta-analysis published in Sleep and Breathing, looking at 32 studies and 2,310 patients, found that bariatric surgery reduced AHI by an average of 19.3 events per hour (95% CI 14.6 to 23.9). A separate 2023 systematic review in Frontiers in Sleep, covering 30 studies and 1,369 patients, found an even larger reduction of 23.2 events per hour. Both meta-analyses agreed on the direction. Surgery works.
Beyond 12 months. This is where the conversation gets honest. The same Sleep and Breathing meta-analysis found that the clinical remission rate of OSA (AHI below 5 events per hour) after bariatric surgery is approximately 65%. That means roughly one in three patients still has measurable OSA after surgery, even after significant weight loss. The Greenburg meta-analysis pooled 13,900 patients and found improvement or resolution in 88.5%, but the bar for "improvement" includes patients still in the mild range who would still benefit from treatment.
Translation: most of my patients do see major improvement. Many can reduce their CPAP pressure or come off CPAP entirely. But you do not get to make that decision based on how you feel. You make it based on a repeat sleep study.
The MOSAIC study: this is not just about CPAP, this is about your heart
In June 2024, the Journal of the American College of Cardiology published the MOSAIC study from the Cleveland Clinic, led by Dr. Ali Aminian. This is the first long-term cardiovascular outcomes study specific to patients with OSA and obesity who underwent metabolic surgery.
The setup: 13,657 patients with BMI 35 to 70 and moderate-to-severe OSA (AHI ≥ 15), followed between 2004 and 2018. 970 had bariatric surgery. 12,687 did not. Median follow-up 5.3 years, with 10-year cumulative incidence estimates.
The findings are striking. The cumulative incidence of major adverse cardiovascular events (MACE) at 10 years was 27% in the surgery group versus 35.6% in the non-surgical group. All-cause mortality at 10 years was 9.1% in surgery versus 12.5% in non-surgical. Surgery was associated with a 42% lower MACE risk and a 37% lower death risk over 10 years.
This study is observational, not randomized. The authors are transparent about that limitation. But the size of the cohort and the consistency with the SOS study (which found a 30.7% reduction in all-cause mortality across all bariatric candidates) makes the direction of the finding very robust.
If you have moderate-to-severe OSA and obesity, this is not a quality-of-life decision. It is a survival decision.
Can I stop using my CPAP after surgery?
Probably yes, eventually. Possibly no. The data says you have to verify.
Here is what I tell every CPAP user before surgery: we are going to repeat your polysomnography 12 months after your operation, ideally with a one-week washout from CPAP before the study. Until that study confirms your AHI has normalized, you keep using your CPAP, even on the nights you feel like you do not need it.
This is not me being conservative. This is published evidence. A study in the Journal of Clinical Sleep Medicine followed bariatric surgery patients with OSA for 7.2 years on average. Most patients in that cohort stopped using their CPAP without confirming their OSA had resolved. The result: persistent OSA in nearly all of them, and significantly more weight regain in the patients who had stopped CPAP compared to those who kept it (about 6 pounds per year of differential weight gain).
There is also a psychological trap here. Patients who used to snore loudly often stop snoring after weight loss. They wake up feeling more rested. They conclude their sleep apnea is gone. But snoring resolution does not equal AHI resolution. The same study found that patients who self-reported no longer snoring were ten times more likely to have inappropriately discontinued CPAP. They felt fine. Their polysomnography told a different story.
So the algorithm in my practice is:
- Post-op month 6: check CPAP pressure settings. As you lose weight, your CPAP pressure usually needs to come down. Too high a pressure becomes uncomfortable and can paradoxically worsen sleep.
- Post-op month 12: full repeat polysomnography. If your AHI is below 5 and your oxygenation is normal, we discuss discontinuation with your sleep specialist.
- After discontinuation: re-check at month 24, and any time you regain weight or symptoms return.
Who should not assume their OSA will resolve
In my experience, the patients least likely to achieve full OSA resolution after surgery are:
- Patients with very severe pre-op OSA (AHI above 60). The disease is too established.
- Older patients, especially those over 60. Airway tissue elasticity decreases with age regardless of weight.
- Patients with anatomical contributors beyond fat: micrognathia (small jaw), retrognathia (recessed jaw), large tonsils, narrow palate.
- Patients with persistent type 2 diabetes after surgery. T2D is an independent risk factor for OSA persistence.
- Patients who regain significant weight in the first 2 to 3 years.
For these patients, surgery still helps dramatically. They will need less CPAP pressure. They will have fewer events. They will probably still need some form of treatment, whether continued CPAP at a lower pressure, a mandibular advancement device, or positional therapy. Surgery is part of the answer, not necessarily the whole answer.
What the Enhanced Gastric Sleeve specifically does for OSA patients
In my practice, every OSA patient who comes through for the Enhanced Gastric Sleeve gets a few specific protocols adjusted for their respiratory status.
We optimize their CPAP use the week before surgery, because better baseline oxygenation reduces anesthetic risk. We use a careful intraoperative airway plan, because the same anatomy that causes OSA also makes intubation harder. The drain-free protocol and pre-emptive pain management mean patients are walking the same day, which is critical for OSA patients because mobility prevents the atelectasis and hypoxic episodes that can occur in the immediate post-op period. We continue CPAP postoperatively for at least the first 2 to 3 nights, and we monitor oxygenation continuously.
These are not generic operative steps. They are decisions that come from operating on a high volume of OSA patients and understanding that the anesthetic vulnerability does not stop the minute the surgery ends.
What about Ozempic or Mounjaro for OSA?
I am asked this often, and I will share what the data actually shows.
In June 2024, the SURMOUNT-OSA trial published in The New England Journal of Medicine showed that tirzepatide (Mounjaro and Zepbound) reduced AHI by 25 events per hour in patients with moderate-to-severe OSA and obesity. That is comparable to the bariatric surgery effect. The FDA subsequently approved tirzepatide for OSA in patients with obesity in late 2024.
This is a meaningful development. For some patients, a GLP-1 may be a reasonable first-line approach.
The caveats are the same ones we discuss in any GLP-1 conversation. You have to stay on it. The cost is significant if not covered. And the weight (and the OSA) typically returns when you stop. The MOSAIC cardiovascular outcomes have not been replicated in a GLP-1 cohort yet. We do not have 10-year mortality data for tirzepatide. We have it for surgery.
If you are 35 years old with severe OSA and a BMI of 42, you are making a decision about the next 30 to 40 years of your life. That math, in my experience, often pushes toward surgery as the more durable solution. But it is a real conversation, not a foregone conclusion.
Quick answers
Will my sleep apnea go away after a gastric sleeve?
It will improve dramatically in most patients. Approximately 65% reach clinical remission (AHI below 5) at 12 months. Some patients still have residual OSA and need continued treatment.
Do I have to keep using my CPAP after surgery?
Yes, until a repeat polysomnography at 12 months confirms your AHI has normalized. Discontinuing CPAP based on how you feel rather than data is associated with weight regain and persistent untreated OSA.
Does bariatric surgery reduce my heart attack risk if I have sleep apnea?
According to the 2024 MOSAIC study, yes. Bariatric surgery was associated with a 42% lower risk of major cardiovascular events and a 37% lower risk of death at 10 years in patients with moderate-to-severe OSA and obesity.
Can I get a gastric sleeve if I have severe sleep apnea?
Yes. We optimize your CPAP use before surgery, manage your airway carefully during the procedure, and continue CPAP for at least the first few nights post-op. Severe OSA is a reason to have surgery, not to avoid it.
Will I still snore after losing weight?
Most patients stop snoring or snore much less. But snoring resolution does not mean your OSA has resolved. The only way to know is a sleep study.
What is the STOP-Bang questionnaire?
A validated 8-item screening tool for OSA. Score of 3 or higher (4 or higher in some bariatric populations) signals a referral for a sleep study. We use it in every bariatric evaluation.
Is gastric bypass better than the sleeve for sleep apnea?
Both work. Gastric bypass produces slightly more weight loss on average and slightly higher OSA remission rates in some studies. The Enhanced Gastric Sleeve has lower complication rates and shorter recovery, so it is often the first choice for OSA patients without other indications.
Can I have surgery if I cannot tolerate CPAP?
Yes. CPAP intolerance is actually a common reason patients seek surgery. We can manage your perioperative airway with other means, including BiPAP and careful anesthetic planning.
What to do next
If you have been diagnosed with OSA, are on CPAP, and you carry significant obesity, you have more options than you have been told. The first step is a virtual consultation, where I will review your sleep study, your STOP-Bang, your current CPAP settings, and your overall metabolic picture. We will talk about whether surgery makes sense for you, what your timeline looks like, and what the post-operative sleep follow-up plan would be.
You can request a free virtual evaluation, and my coordinator Lucia will reach out to schedule. We move at your pace.
Sleep apnea is not just a quality-of-life issue. It is a survival issue. The data on bariatric surgery in this population is some of the strongest in metabolic medicine.
For the complete picture of how bariatric surgery affects all major obesity-related conditions, including procedure-specific differences and honest comparisons with GLP-1 medications across each condition, see the comprehensive evidence guide.
Sources
- Aminian A, Wang L, Al Jabri A, et al. Adverse Cardiovascular Outcomes in Patients With Obstructive Sleep Apnea and Obesity: Metabolic Surgery vs Usual Care. J Am Coll Cardiol. 2024;84(7):589-602. doi:10.1016/j.jacc.2024.06.008
- Al Oweidat K, Toubasi AA, Abu Tawileh RB, Abu Tawileh HB, Hasuneh MM. Bariatric surgery and obstructive sleep apnea: a systematic review and meta-analysis. Sleep Breath. 2023;27(6):2283-2294. PMID: 37145243
- The impact of bariatric surgery on breathing-related polysomnography parameters: an updated systematic review and meta-analysis. Frontiers in Sleep. 2023. PMC12713882
- Greenburg DL, Lettieri CJ, Eliasson AH. Effects of surgical weight loss on measures of obstructive sleep apnea: a meta-analysis. Am J Med. 2009;122(6):535-542.
- Lettieri CJ, Eliasson AH, Greenburg DL. Persistence of Obstructive Sleep Apnea After Surgical Weight Loss. J Clin Sleep Med. 2008;4(4):333-338. PMC2542489
- Sjöström L. Review of the key results from the Swedish Obese Subjects (SOS) trial: a prospective controlled intervention study of bariatric surgery. J Intern Med. 2013;273(3):219-234. PMID: 23163728
- Chung F, Memtsoudis SG, Ramachandran SK, et al. Society of Anesthesia and Sleep Medicine Guideline on Preoperative Screening and Assessment of Adult Patients With Obstructive Sleep Apnea. Anesth Analg. 2016;123(2):452-473.
- Malhotra A, Grunstein RR, Fietze I, et al. Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity (SURMOUNT-OSA). N Engl J Med. 2024;391(13):1193-1205.
- Eisenberg D, Shikora SA, Aarts E, et al. 2022 American Society for Metabolic and Bariatric Surgery (ASMBS) and IFSO: indications for metabolic and bariatric surgery. Surg Obes Relat Dis. 2022;18(12):1345-1356.
Authored by Dr. Gabriela Rodríguez Ruiz, MD, PhD, FACS. Updated based on the 2024 MOSAIC study (JACC), the 2024 SURMOUNT-OSA trial (NEJM), and the latest systematic reviews on bariatric surgery and OSA outcomes.
